We start the new year with our regular monthly trawl for new publications from HEDS in collaboration with colleagues in ScHARR and further afield and it has reaped a tremendous amount of fresh research. Many of these are currently in press, so you can find much of our work in its open access form via our institutional repository. Find them here: http://eprints.whiterose.ac.uk/view/iau/Sheffield=2EHRR.html
Biesty, L., Meskell, P.,
Glenton, C., Delaney, H., Smalle, M., Booth, A., Chan, X. H. S., Devane, D.,
& Houghton, C. (2020). A QuESt for speed : rapid qualitative evidence
syntheses as a response to the COVID-19 pandemic. Systematic Reviews, 9(1).
https://doi.org/10.1186/s13643-020-01512-5
International Journal of Health
Policy and Management
Booth, A., Laar, A.,
Barnes, A., Akparibo, R., Graham, F., Bash, K., Asiki, G., & Holdsworth, M.
(n.d.). Policy Action within urban African Food Systems to Promote Healthy Food
Consumption: a realist synthesis in Ghana and Kenya. International Journal
of Health Policy and Management.
Dodd, P., Yuen, C.,
Jayasooriya, S., van der Zalm, M., & Seddon, J. (n.d.). Quantifying the
global number of tuberculosis survivors: a modelling study. Lancet
Infectious Diseases.
Gray, L. (2020). BMI
trajectories, mortality and comorbidity in older adults. Value in Health,
23(Supplement 2), S608–S608. https://doi.org/10.1016/j.jval.2020.08.1242
Hardern, C., Lee, D.,
Sly, I., & Kearns, B. (2020). EX2 Structural Uncertainty in Survival
Extrapolation: Exploring the IMPACT of FOUR MODEL Averaging Methods and
Adjusting for DATA Maturity. Value in Health, 23, S402–S402.
https://doi.org/10.1016/j.jval.2020.08.027
Jen-Yu Amy, C., Latimer, N. R., Gillespie, D., & Chilcott, J. (2020). PMU17 Prevalence, Characteristics and Key Issues of Modelling Treatment Sequences in Health Economic Evaluations: A Systematic Review of Nice Technology Appraisals. In Value in Health (Vol. 23, pp. S606–S606). Elsevier BV. https://doi.org/10.1016/j.jval.2020.08.1229
Jin, H., Tappenden, P., MacCabe, J. H., Robinson, S., McCrone, P., & Byford, S. (n.d.). Cost and health impacts of adherence to the National Institute for Health and Care Excellence schizophrenia guideline recommendations. The British Journal of Psychiatry, 1–6. https://doi.org/10.1192/bjp.2020.241
Kearns, B., Cooper, K.,
& Cantrell, A. (2020). PMU13 Schizophrenia Treatment with Second-Generation
Antipsychotics: A MULTI-Country Evaluation of the Costs of Cardiovascular and
Metabolic Adverse Events and Weight GAIN. Value in Health, 23,
S605–S605. https://doi.org/10.1016/j.jval.2020.08.1225 abstract
Kearns, B., Cooper, K.,
Cantrell, A., & Thomas, C. (n.d.). Schizophrenia treatment with
second-generation antipsychotics: a multi-country comparison of the costs of
cardiovascular and metabolic adverse events and weight gain. Neuropsychiatric
Disease and Treatment.
Martin, C., Shrestha,
A., Morgan, J., Bradburn, M., Herbert, E., Burton, M., Todd, A., Walters, S.,
Ward, S., Holmes, G., Reed, M., Collins, K., Robinson, T. G., Ring, A., Cheung,
K. L., Audisio, R., Gath, J., Revell, D., Green, T., … Wyld, L. (2020).
Treatment choices for older women with primary operable breast cancer and
cognitive impairment: Results from a prospective, multicentre cohort study. Journal
of Geriatric Oncology. https://doi.org/10.1016/j.jgo.2020.12.006
Matza, L. S., Stewart,
K. D., Lloyd, A., Rowen, D., & Brazier, J. (n.d.). Vignette-Based
Utilities: Usefulness, Limitations, and Methodological Recommendations. Value
in Health.
McNamara, S., Tsuchiya,
A., & Holmes, J. (2020). Does the UK-public’s aversion to inequalities in
health differ by group-labelling and health-gain type? A choice-experiment. Social
Science & Medicine. https://doi.org/10.1016/j.socscimed.2020.113573
Mshelia, S. E., Analo,
C. V, & Booth, A. (n.d.). Factors influencing the utilisation of
facility-based delivery in Nigeria: a qualitative evidence synthesis. Journal
of Global Health Reports. https://doi.org/10.29392/001c.17961
Mukuria, C., Rowen, D.,
Brazier, J. E., McGarry, L., Quittner, A., Lou, Y., Sosnay, P., & Acaster,
S. (2020). PR1 Comparison of the Psychometric Performance of a New
Condition-Specific Preference-Based Measure Derived from the Cfq-R (CFQ-R-8D)
to EQ-5D-3L and SF-6D to Evaluate Health-Related Quality-of Life (HRQOL) in
People with Cystic Fibrosis (CF). Value in Health, 23, S689–S689.
https://doi.org/10.1016/j.jval.2020.08.1732
Development and
Psychopathology
Newton, K., Taylor Buck,
E., Weich, S., & Uttley, L. (2020). A review and analysis of the components
of potentially effective perinatal mental health interventions for infant
development and mother-infant relationship outcomes. Development and
Psychopathology. https://doi.org/10.1017/s0954579420001340
Peasgood, T., Mukuria,
C., Carlton, J., Connell, J., & Brazier, J. (n.d.). Criteria for item
selection for a preference-based measure for use in economic evaluation. Quality
of Life Research. https://doi.org/10.1007/s11136-020-02718-9
Richards, D., Enrique,
A., Eilert, N., Franklin, M., Palacios, J., Duffy, D., Earley, C., Chapman, J.,
Jell, G., Sollesse, S., & Timulak, L. (2020). Author Correction: A
pragmatic randomized waitlist-controlled effectiveness and cost-effectiveness
trial of digital interventions for depression and anxiety. Npj Digital
Medicine, 3(1). https://doi.org/10.1038/s41746-020-0298-3
Romero, C. P., Marinho,
D. S., Castro, R., de Aguiar Pereira, C. C., Silva, E., Caetano, R., Silva
Elias, F. T., Chilcott, J., & Dixon, S. (2020). Cost-effectiveness analysis
of point-of-care rapid testing versus laboratory-based testing for antenatal
screening of syphilis in Brazil. Value in Health Regional Issues, 23,
61–69. https://doi.org/10.1016/j.vhri.2020.03.004
Scarisbrick, J.,
Schmidt, F., Turini, M. M., D’agostino, P., Thornton, S., Evans, J., Ader, J.,
van Hest, N., & Brazier, J. E. (2020). PRO140 Health-Related Quality of
Life Associated with Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma Patients:
Determination of Utility Values from a UK-Based Clinician Questionnaire. Value
in Health, 23, S715–S715.
https://doi.org/10.1016/j.jval.2020.08.1876
Schneider, P. P., Smith,
R. A., Bullas, A. M., Quirk, H., Bayley, T., Haake, S. J., Brennan, A., &
Goyder, E. (2020). Multiple deprivation and geographic distance to community
physical activity events — achieving equitable access to parkrun in England. Public
Health, 189, 48–53. https://doi.org/10.1016/j.puhe.2020.09.002
Shah, K., Bennett, B.,
Lenny, A., Longworth, L., Brazier, J. E., Oppe, M., Pickard, A. S., & Shaw,
J. W. (2020). PCN48 Adapting Preference-Based Utility Measures to Capture the
Impact of Cancer Treatment-Related Symptoms. Value in Health, 23,
S430–S430. https://doi.org/10.1016/j.jval.2020.08.185
Srivastava, T., Latimer,
N. R., & Tappenden, P. (2020). PMU78 Estimation of Transition Probabilities
for State-Transition Models: A Review of NICE Appraisals. In Value in Health
(Vol. 23, pp. S615–S616). Elsevier BV.
https://doi.org/10.1016/j.jval.2020.08.1290Obesity Reviews
Tai, T.-A., Latimer, N.,
Benedict, A., Kiss, Z., & Nikolaou, A. (2020). Prevalence of immature
survival data for anti-cancer drugs presented to the National Institute for
Health and Care Excellence and impact on decision making. Value in Health.
https://doi.org/10.1016/j.jval.2020.10.016
Trübswasser, U.,
Verstraeten, R., Salm, L., Holdsworth, M., Baye, K., Booth, A., Feskens, E. J.
M., Gillespie, S., & Talsma, E. F. (n.d.). Factors influencing obesogenic
behaviours of adolescent girls and women in low‐ and middle‐income countries: A
qualitative evidence synthesis. Obesity Reviews, obr.13163.
https://doi.org/10.1111/obr.13163